Last reviewed · How we verify
NCT07394504
Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy
NA trial testing Turning Based Dual Task Training in Diabetic Neuropathy in 44 participants. Currently enrolling.
10 March 2026
Quick facts
| Lead sponsor | Foundation University Islamabad |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 44 |
| Start date | 20 November 2025 |
| Primary completion | 10 March 2026 |
| Estimated completion | 5 June 2026 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Turning Based Dual Task Training
- Dual-Task Training
Conditions studied
- Diabetic Neuropathy — all drugs for Diabetic Neuropathy →
- Balance — all drugs for Balance →
- Cognitive Dysfunction — all drugs for Cognitive Dysfunction →
- Cognitive Decline — all drugs for Cognitive Decline →
Sponsor
Foundation University Islamabad
Who can join
50 and older, any sex, with Diabetic Neuropathy or Balance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Diabetic Peripheral Neuropathy (DPN) is a common complication of diabetes, characterized by impaired sensory and motor function, often leading to balance dysfunction and an increased risk of falls. Additionally, individuals with DPN are at heightened risk for mild cognitive impairment (MCI), which further compromises functional independence. This study aims to determine the effects of turning-based dual-task training compared to conventional dual-task training on balance, cognitive function, and fall risk in individuals with DPN. Pre- and post-intervention assessments will be conducted using the Berg Balance Scale (BBS), Montreal Cognitive Assessment (MoCA), and Timed Up and Go Test (TUGT) to evaluate balance, cognition, and fall risk respectively.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07394504
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetic Neuropathy
Currently open trials in the same condition.
- NCT07272993 — Effect of Golden Rice-Piper Crocatum Cookies on Neuropathy Prevention in Diabetes · NA · active not recruiting
- NCT07036796 — Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy · Phase 2 · recruiting
- NCT06958302 — The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients · recruiting
- NCT06668623 — Effect of Reiki on Neuropathic Pain Severity and Sleep Quality in Patients With Diabetic Neuropathy · NA · recruiting
- NCT07210203 — Additional Effects of Neural Mobilization on Pain, Balance and Quality of Life in Diabetic Neuropathy · NA · recruiting
Other Foundation University Islamabad trials
Trials by the same sponsor.
- NCT07485777 — Comparative Evaluation of Topical 30% Metformin and Kligman's Regimen in Women With Melasma · NA · not yet recruiting
- NCT07495748 — Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma · NA · not yet recruiting
- NCT07519174 — A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% i · NA · not yet recruiting
- NCT07526051 — Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome · NA · recruiting
- NCT07526012 — Comparative Effects Of Post Isometric Relaxation Versus Active Isolated Stretch In Patients With Piriformis Syndrome · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07394504 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Foundation University Islamabad
- Last refreshed: 6 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07394504.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing